Skip to main content

Advertisement

Sections

Page 38 of 38

  1. Content type: Meeting report

    The Workshop associated with the 27th Annual Meeting of the Society for Immunotherapy of Cancer (SITC), North Bethesda, MD, October 24-25, 2012 focused on targeting the tumor microenvironment as part of an int...

    Authors: Melek Erdinc Sunay, Francesco Marincola, Samir N Khleif, Samuel C Silverstein, Bernard A Fox, Jerome Galon and Leisha A Emens

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:9

    Published on:

  2. Content type: Research article

    CEA is expressed in >90% of pancreatic cancers (PC) and may be an appropriate immunotherapy target. CEA is poorly immunogenic due to immune tolerance; CAP1-6D, an altered peptide ligand can help bypass toleran...

    Authors: Daniel M Geynisman, Yuanyuan Zha, Rangesh Kunnavakkam, Mebea Aklilu, Daniel VT Catenacci, Blase N Polite, Cara Rosenbaum, Azadeh Namakydoust, Theodore Karrison, Thomas F Gajewski and Hedy L Kindler

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:8

    Published on:

  3. Content type: Research article

    We have developed a novel approach to categorize immunity in patients that uses a combination of whole blood flow cytometry and hierarchical clustering.

    Authors: Michael P Gustafson, Yi Lin, Betsy LaPlant, Courtney J Liwski, Mary L Maas, Stacy C League, Philippe R Bauer, Roshini S Abraham, Matthew K Tollefson, Eugene D Kwon, Dennis A Gastineau and Allan B Dietz

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:7

    Published on:

  4. Content type: Review

    Immunotherapeutics include drugs and biologics that render therapeutic benefit by harnessing the power of the immune system. The promise of immune-mediated therapies is target specificity with a consequent red...

    Authors: Ramjay S Vatsan, Peter F Bross, Ke Liu, Marc Theoret, Angelo R De Claro, Jinhua Lu, Whitney Helms, Brian Niland, Syed R Husain and Raj K Puri

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:5

    Published on:

  5. Content type: Meeting report

    The 27th annual meeting of the Society for Immunotherapy of Cancer (SITC) was held on October 26–28, 2012 in North Bethesda, Maryland and the highlights of the meeting are summarized. The topics covered at this m...

    Authors: David F Stroncek, Cornelis JM Melief, Luciano Castiello, Alessandra Cesano, Martin A Cheever, Sara Civini, Begonya Comin-Anduix, Thomas F Gajewski, Philip D Greenberg, Pawel Kalinski, Howard L Kaufman, Michael H Kershaw, Samir N Khleif, Francesco Marincola, William Merritt, David H Munn…

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:4

    Published on:

  6. Content type: Short report

    Treatment with agonist anti-CD137 (4-1BB) immunostimulatory monoclonal antibodies elicits complete tumor regressions in a number of transplanted hematological and solid malignancies in mice. Rejection is mainl...

    Authors: Aizea Morales-Kastresana, Elena Catalán, Sandra Hervás-Stubbs, Asis Palazón, Arantza Azpilikueta, Elixabet Bolaños, Alberto Anel, Julián Pardo and Ignacio Melero

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:3

    Published on:

  7. Content type: Research article

    Antigen-specific anti-tumor vaccines have demonstrated clinical efficacy, but immunological and clinical responses appear to be patient-dependent. We hypothesized that naturally-occurring differences in amino ...

    Authors: Jordan T Becker and Douglas G McNeel

    Citation: Journal for ImmunoTherapy of Cancer 2013 1:2

    Published on:

Annual Journal Metrics

Advertisement